PHASE-II STUDY OF IFOSFAMIDE-ETOPOSIDE-MESNA IN ADULTS WITH ADVANCED NONOSSEOUS SARCOMAS

被引:21
作者
EDMONSON, JH
BUCKNER, JC
LONG, HJ
LOPRINZI, CL
SCHAID, DJ
机构
关键词
D O I
10.1093/jnci/81.11.863
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:863 / 866
页数:4
相关论文
共 11 条
[1]  
ANTMAN KH, 1985, CANCER TREAT REP, V69, P499
[2]  
BRAMWELL V, 1985, P AN M AM SOC CLIN, V4, P143
[3]  
BURKERT H, 1982, SEMIN ONCOL, V9, P28
[4]  
EDMONSON JH, 1985, CANCER CHEMOTH PHARM, V15, P181
[5]   HIGH-DOSE IFOSFAMIDE AND MESNA AS CONTINUOUS INFUSION OVER 5 DAYS - A PHASE-I PHASE-II TRIAL [J].
KLEIN, HO ;
WICKRAMANAYAKE, PD ;
COERPER, C ;
CHRISTIAN, E ;
POHL, J ;
BROCK, N .
CANCER TREATMENT REVIEWS, 1983, 10 :167-173
[6]  
MAGRATH IT, 1985, P ASCO, V4, P136
[7]  
MARTI C, 1985, CANCER TREAT REP, V69, P115
[8]  
MISER J, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P209
[9]  
MISER J, 1988, P AN M AM SOC CLIN, V7, P258
[10]   IFOSFAMIDE WITH MESNA UROPROTECTION AND ETOPOSIDE - AN EFFECTIVE REGIMEN IN THE TREATMENT OF RECURRENT SARCOMAS AND OTHER TUMORS OF CHILDREN AND YOUNG-ADULTS [J].
MISER, JS ;
KINSELLA, TJ ;
TRICHE, TJ ;
TSOKOS, M ;
JAROSINSKI, P ;
FORQUER, R ;
WESLEY, R ;
MAGRATH, I .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) :1191-1198